AKT1 and pachyonychia congenita: In combination with biomaterials, Cunha and associates (20) reported that EGCG might increase gemcitabine sensitivity, moderately obstructing the Akt pathway to curtail the migration, invasion, and epithelial–mesenchymal transition of PC cells.